← back to search

Rachel Sacks‐Davis

Burnet Institute · AU
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Hepatitis C virus research, HIV, Drug Use, Sexual Risk, Hepatitis B Virus Studies, and Liver Disease Diagnosis and Treatment.
h-index
32
citations
3,446
works
121
NIH funding
primary concept
email

Recent publications

Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis
˜The œLancet. Gastroenterology & hepatology 2023cited by 94position: middledoi
Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
The Lancet Public Health 2021cited by 207position: middledoi
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
The Lancet Infectious Diseases 2018cited by 226position: middledoi
Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users
Science Translational Medicine 2018cited by 45position: middledoi
Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection—the InC<sup>3</sup>Study
The Journal of Infectious Diseases 2015cited by 92position: firstdoi
Patterns of Hepatitis C Virus RNA Levels during Acute Infection: The InC3 Study
PLoS ONE 2015cited by 73position: middledoi
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection
Hepatology 2013cited by 392position: middledoi
High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study
PLoS ONE 2013cited by 69position: firstdoi
The More You Look, the More You Find: Effects of Hepatitis C Virus Testing Interval on Reinfection Incidence and Clearance and Implications for Future Vaccine Study Design
The Journal of Infectious Diseases 2012cited by 68position: middledoi
Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia
The Medical Journal of Australia 2012cited by 57position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Margaret Hellard · Victoria University6 papers (2012–2015)Jason Grebely · UNSW Sydney5 papers (2012–2015)Kimberly Page · University of New Mexico5 papers (2012–2018)Gregory J. Dore · UNSW Sydney4 papers (2012–2015)Andrea L. Cox · Johns Hopkins University4 papers (2012–2015)Behzad Hajarizadeh · UNSW Sydney4 papers (2013–2018)Maria Prins · KWR Water Research Institute3 papers (2013–2015)Julie Bruneau · McGill University3 papers (2013–2015)Janke Schinkel · Amsterdam Neuroscience3 papers (2013–2015)Meghan D. Morris · University of California, San Francisco3 papers (2013–2015)Lisa Maher · UNSW Sydney3 papers (2013–2015)Arthur Y. Kim · Harvard University3 papers (2013–2015)Andrew R. Lloyd · UNSW Sydney3 papers (2013–2015)Barbara McGovern · Seres Therapeutics (United States)3 papers (2013–2015)Peter Vickerman · At Bristol2 papers (2012–2012) · 2 papers (2013–2015)William O. Osburn · Johns Hopkins Medicine2 papers (2012–2015)Jacob George · The University of Sydney2 papers (2013–2013)Matthew Hickman · University of Bristol2 papers (2012–2012)Campbell Aitken · Monash University2 papers (2012–2013)